查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1917892

藥物濫用治療市場－2026-2031年預測

Substance Abuse Treatment Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計藥物濫用治療市場將從 2025 年的 168.85 億美元成長到 2031 年的 254.55 億美元，複合年成長率為 7.08%。

藥物濫用治療市場是醫療保健系統中重要且不斷成長的組成部分，它透過持續的醫療、行為和社會心理干預來應對成癮這一複雜挑戰。該市場涵蓋廣泛的服務，包括戒毒、藥物輔助性治療(MAT)、住院和門診康復、諮詢以及長期康復支持。推動其成長的因素包括：物質使用障礙 (SUD) 的持續高發生率、鴉片類藥物成癮持續的公共衛生危機、循證治療標準的不斷發展，以及對以患者為中心的綜合護理模式的日益重視，這些模式旨在解決成癮的多方面問題。

推動市場擴張的一個根本且強大的因素是全球物質使用障礙的高發生率及其持續成長。對鴉片類藥物、酒精、興奮劑和其他物質的依賴造成了嚴重的公共衛生負擔，導致發病率和死亡率上升，並帶來巨大的社會經濟成本。受影響人群的龐大規模使得對便捷有效的治療服務的需求持續成長。公眾和政府日益增強的意識進一步推動了這一需求，他們認知到成癮是一種慢性、可治療的疾病，而非道德缺陷。這減少了社會歧視，並鼓勵更多人尋求幫助。

持續不斷的鴉片危機，尤其是在北美地區，已成為推動市場關注和創新的實際而深遠的催化劑。這場危機凸顯了有效治療方法的迫切性，並促成了重大的政策變革、資金分配和臨床措施。這顯著擴大了藥物輔助性治療（MAT）的普及和應用。 MAT將FDA認證核可藥（例如Buprenornhine、美沙酮和納曲酮）與諮商和行為療法結合。 MAT被公認為鴉片類藥物使用障礙治療的黃金標準，其廣泛應用是治療市場發展的驅動力，有助於提高治療依從性並降低致命性過量用藥的風險。

同時，實證治療方法的普及和完善正在重塑市場格局。該領域正從傳統的「一刀切」式方法轉向臨床研究中已證實有效的干涉措施。這包括認知行為療法（CBT）、緊急管理和動機式訪談等特定行為療法，這些療法已被證明能有效減少物質濫用並預防復發。將這些實證實踐融入標準治療通訊協定，不僅能改善患者預後，還能確保獲得保險報銷，並在醫療服務網路中建立更高的護理標準。

一個關鍵趨勢是轉向全面、個人化的照護模式，將成癮視為一種生物心理社會疾病。有效的治療現在通常同時關注共存的精神疾病（雙重診斷）、潛在創傷、社會健康決定因素以及整體健康狀況。這種綜合辦法需要一個由醫生、精神科醫生、治療師和社會工作者組成的多學科團隊來制定個人化的治療方案。這種關注“整體治療”，而不僅僅是治療成癮，可以提高患者的參與度、治療依從性和長期康復成功率，也是高品質醫療機構之間的關鍵區別所在。

從地理位置來看，北美在市場上佔據主導地位。這項優勢歸功於物質使用疾患（SUDs）的高發生率，尤其是鴉片類藥物使用疾患；相對完善的治療基礎設施；大量的公共和私人資金投入成癮服務；以及逐步支持擴大藥物輔助性治療（MAT）覆蓋法規環境。專業治療機構的集中以及為應對成癮危機而持續推出的政策舉措，進一步鞏固了該地區的核心地位。

服務模式涵蓋不同程度的護理，以滿足不同程度的病情和患者的需求。這些模式包括醫療監管下的住院戒毒、強化型住宅復健、部分住院治療項目（PHP）、強化門診治療計畫（IOP）以及標準門診諮詢。目前的趨勢是建立一個整合的連續性照護體系，允許在患者的整個治療過程中逐步調整治療強度，從而提高照護的連續性，並減少可能導致復發的服務缺口。

競爭格局包括專注於行為健康的上市大規模醫療保健機構、全國性非營利治療組織以及眾多區域性和地方性診所。關鍵競爭因素包括臨床品質和治療效果、認證狀態、提供全面雙重診斷護理的能力、醫保網路覆蓋範圍以及提供全面服務系統的能力。策略性成長通常包括併購和聯盟，以擴大地域覆蓋範圍和服務能力。

總之，為因應嚴峻且持續的公共衛生需求，藥物濫用治療市場不斷發展演變。其成長動力源自於成癮流行、鴉片類藥物危機的特異性性以及更有效、更人性化、更全面的照護模式的日益成熟。未來市場發展將受到以下因素的影響：進一步將成癮治療融入主流醫療保健體系；解決合格臨床醫生短缺問題；克服服務不足地區的就醫障礙；以及確保循證服務的永續報銷。這一市場發展軌跡體現了社會對為慢性病患者提供有效且有尊嚴的護理，以及幫助個人和社區恢復健康、功能和希望的堅定承諾。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

您打算如何使用這份報告？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 按物質類型分類的藥物濫用治療市場

  • 介紹
  • 酒精
  • 鴉片類藥物
  • 大麻
  • 其他

6. 按治療類型分類的藥物濫用治療市場

  • 介紹
  • 行為療法
  • 藥物輔助治療（MAT）
  • 戒毒療法
  • 其他

7. 按應用分類的藥物濫用治療市場

  • 介紹
  • 住院設施
  • 門診設施

8. 各地區的藥物濫用治療市場

  • 介紹
  • 北美洲
    • 藥物
    • 按治療類型
    • 透過使用
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 藥物
    • 按治療類型
    • 透過使用
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 藥物
    • 按治療類型
    • 透過使用
    • 按國家/地區
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 義大利
      • 其他
  • 中東和非洲
    • 藥物
    • 按治療類型
    • 透過使用
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 藥物
    • 按治療類型
    • 透過使用
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Acadia Healthcare Company, Inc.
  • Hazelden Betty Ford Foundation
  • Promises Behavioral Health
  • Caron Treatment Center
  • Behavioral Health Group（Bhg）
  • Crossroads Treatment Centers
  • Sandstone Care
  • American Addiction Centers, Inc.
  • Mayo Clinic
  • Pelago

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615957

Substance Abuse Treatment Market is projected to expand at a 7.08% CAGR, attaining USD 25.455 billion in 2031 from USD 16.885 billion in 2025.

The substance abuse treatment market is a critical and expanding segment of the global healthcare system, dedicated to addressing the complex challenges of addiction through a continuum of medical, behavioral, and psychosocial interventions. This market encompasses a wide range of services, including detoxification, medication-assisted treatment (MAT), inpatient and outpatient rehabilitation, counseling, and long-term recovery support. Its growth is driven by the persistent and rising prevalence of substance use disorders (SUDs), the ongoing public health crisis of opioid addiction, evolving evidence-based treatment standards, and an increasing emphasis on holistic, patient-centered care models that address the multifaceted nature of addiction.

A fundamental and powerful driver of market expansion is the high and increasing global prevalence of substance use disorders. Addiction to opioids, alcohol, stimulants, and other substances represents a significant burden on public health, contributing to morbidity, mortality, and substantial socioeconomic costs. The sheer scale of affected individuals creates a sustained and growing demand for accessible, effective treatment services. This demand is further intensified by heightened public and governmental awareness of addiction as a chronic, treatable medical condition rather than a moral failing, which is reducing stigma and encouraging more individuals to seek help.

The ongoing opioid epidemic, particularly in North America, represents a specific and acute catalyst for market focus and innovation. The crisis has underscored the urgent need for effective treatment modalities and has driven significant policy changes, funding allocations, and clinical initiatives. This has led to a substantial expansion in the availability and utilization of medication-assisted treatment (MAT), which combines FDA-approved medications (such as buprenorphine, methadone, and naltrexone) with counseling and behavioral therapies. MAT is recognized as the gold standard for opioid use disorder, and its broader adoption is a major factor propelling the treatment market forward, improving retention in care and reducing the risk of fatal overdose.

Parallel to this, the market is being shaped by the widespread adoption and refinement of evidence-based treatment modalities. The field is moving beyond traditional, one-size-fits-all approaches toward interventions with demonstrated efficacy in clinical research. This includes specific behavioral therapies like cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing, which are proven to reduce substance use and prevent relapse. The integration of these evidence-based practices into standard treatment protocols is improving patient outcomes, justifying reimbursement, and establishing higher standards of care across provider networks.

A significant trend is the shift toward holistic and individualized care models that recognize addiction as a biopsychosocial disorder. Effective treatment now routinely addresses co-occurring mental health conditions (dual diagnosis), underlying trauma, social determinants of health, and overall wellness. This comprehensive approach involves multidisciplinary teams of physicians, psychiatrists, therapists, and social workers creating personalized treatment plans. The focus on treating the whole person-not just the addiction-improves engagement, treatment retention, and long-term recovery success, making it a key differentiator for high-quality providers.

Geographically, North America maintains a dominant position in the market. This leadership is attributed to a high prevalence of SUDs, particularly opioid use disorder; a relatively well-developed treatment infrastructure; significant public and private funding for addiction services; and a regulatory environment that has progressively supported the expansion of treatment access, especially for MAT. The region's concentration of specialized treatment centers and ongoing policy initiatives to combat the addiction crisis further solidify its central role.

The service delivery model spans various levels of care to match patient acuity and need. This includes medically managed inpatient detoxification, residential rehabilitation for intensive therapy, partial hospitalization programs (PHP), intensive outpatient programs (IOP), and standard outpatient counseling. The trend is toward creating integrated care continua that allow patients to step up or down in intensity based on their progress, improving continuity of care and reducing gaps in service that can lead to relapse.

The competitive landscape includes large publicly traded healthcare providers specializing in behavioral health, national non-profit treatment organizations, and a vast number of local and regional clinics. Key competitive factors include clinical quality and outcomes, accreditation, the ability to provide integrated dual diagnosis care, payer network coverage, and the capacity to offer a full continuum of services. Strategic growth often involves mergers, acquisitions, and partnerships to expand geographic reach and service capabilities.

In conclusion, the substance abuse treatment market is evolving in response to a profound and persistent public health need. Its growth is fueled by the escalating prevalence of addiction, the specific urgency of the opioid crisis, and the maturation of more effective, compassionate, and comprehensive care models. Future market development will be shaped by efforts to further integrate addiction treatment into mainstream healthcare, address workforce shortages of qualified clinicians, overcome barriers to access in underserved areas, and secure sustainable reimbursement for evidence-based services. The market's trajectory reflects a critical societal effort to provide effective, dignified care for a chronic condition, with the goal of restoring health, function, and hope to individuals and communities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Substance Abuse Treatment Market Segmentation

  • By Substance
  • Alcohol
  • Opioids
  • Marijuana
  • Others
  • By Treatment Type
  • Behavioral Therapy
  • Medication-Assisted Treatment (MAT)
  • Detoxification
  • Others
  • By Application
  • In-Patient Facility
  • Outpatient Facility
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SUBSTANCE ABUSE TREATMENT MARKET BY SUBSTANCE

  • 5.1. Introduction
  • 5.2. Alcohol
  • 5.3. Opioids
  • 5.4. Marijuana
  • 5.5. Others

6. SUBSTANCE ABUSE TREATMENT MARKET BY TREATMENT TYPE

  • 6.1. Introduction
  • 6.2. Behavioral Therapy
  • 6.3. Medication-Assisted Treatment (MAT)
  • 6.4. Detoxification
  • 6.5. Others

7. SUBSTANCE ABUSE TREATMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. In-Patient Facility
  • 7.3. Outpatient Facility

8. SUBSTANCE ABUSE TREATMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Substance
    • 8.2.2. By Treatment Type
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Substance
    • 8.3.2. By Treatment Type
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Substance
    • 8.4.2. By Treatment Type
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Substance
    • 8.5.2. By Treatment Type
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Substance
    • 8.6.2. By Treatment Type
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Acadia Healthcare Company, Inc.
  • 10.2. Hazelden Betty Ford Foundation
  • 10.3. Promises Behavioral Health
  • 10.4. Caron Treatment Center
  • 10.5. Behavioral Health Group (Bhg)
  • 10.6. Crossroads Treatment Centers
  • 10.7. Sandstone Care
  • 10.8. American Addiction Centers, Inc.
  • 10.9. Mayo Clinic
  • 10.10. Pelago

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations